This is an issue brief which provides an overview of the coverage and cost of several forms of medications for opioid use disorder (MOUD) for individuals with private insurance, Medicare, or Medicaid. The report also provides inconsistencies in policy among private and public health insurance programs and makes recommendations for promoting equitable coverage of MOUD for all insured patients.